On July 9, 2020, ADBiotech Co., Ltd. (XKON:A179530) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,500 KRW | +9.89% | +33.59% | +6.87% |
1st Jan change | Capi. | |
---|---|---|
+6.87% | 21.31M | |
-13.83% | 77.98B | |
+24.00% | 3.66B | |
+0.14% | 3.26B | |
+14.70% | 1.63B | |
-4.46% | 1.6B | |
+2.54% | 1.34B | |
-22.01% | 1.31B | |
-12.12% | 1.18B | |
+1.55% | 1.11B |
- Stock Market
- Equities
- A179530 Stock
- News ADBiotech Co., Ltd.
- ADBiotech Co., Ltd. announced that it has received KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.